Stock info Henry Schein | Filter  Basic-Info

Henry Schein

Henry Schein has located her head office Melville. Henry Schein is active in the health care eq. & services sector. The CEO of Henry Schein is Stanley M Bergman. Donald J. Kabat leads the company as CFO. The period from 2006 till the end of 2016 the international sector gained around 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.

The past year yielded positive returns for Henry Schein investors

Over the last 12 months, that were loss-making period for the investors in Henry Schein, the stock lost around 1 percent. Over the past 5 years the stock rose a massive 136,27 percent. Henry Schein's revenues between 2011 and 2015 were very constant and moved between 8,94 billion dollars and 10,63 billion dollars. Henry Schein's net results between 2011 and 2015 were far from constant and moved between 389,1 million dollars and 509,37 million dollars.

Over the past 5 years the American company paid out dividends.

Henry Schein financed with relatively low debt

At the end of 2015 the American company had a balance sheet of 6,5 billion dollars. Last year the total debt of the company was 3,62 billion dollars. This equals around 55,66 percent of the total balance sheet. As per the end of 2015 Henry Schein's price/earnings-ratio equaled 22. So investors paid for 1 stock 22 times the earnings per share of 2015. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the health care company equaled around 12,86 billion dollars. At the end of 2015 the American company had around 82,42 million stocks listed on the exchanges.

All Henry Schein's financial reports are available here. More information about Henry Schein can be found it's website. .